iTeos Therapeutics Announces $120 Million Registered Direct Offering
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
PulseSelectâ„¢ pulsed field ablation system receives approval in Japan,[...]
06/27/2022 | Press release | Distributed by Public on 06/27/2022 13:18
Please select the service you want to use:
Smartlinks | SEC - The United States Securities and Exchange Commission | News | Crime and Judiciary | Judiciary | Welfare Policy | Politics and Policy | Economic Policy | Welfare Policy | Policy and Regulation | Government | National Government | Economy | Macro Economics | Economic Policy | Pension and Social Security | Financial Services | Judiciary | Financial Regulatory Authorities
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact